top
    Home
    Welcome Note
    Registration
    Accommodation
    Contact Us
     Home
     Welcome Note
     Congress Chairpersons
     Scientific Committee
     Faculty
     Scientific Program
     Timetable
     CME
     Young Investigators Posters
         Poster List
         Poster Award Ceremony
         Poster Presentation Guidelines
     Sponsorship & Exhibition
     Sponsors
     Past Sponsors
     Endorsements
     Registration
         Invitation Letter
     Accommodation
         Leonardo Royal Hotel Berlin
     General Information
         At the C-Hep Congress
         C-Hep 2012 Photos
         Before you travel...
         Tips and Hints
         Transportation
         Italian Agent
         Chinese Agent
     Partners
     About Berlin
     C-Hep 2011
  

 
  Timetable Print
To view the full session, please click on the session number

 
Thursday, October 18, 2012
Hall A
14:00-16:00
Plenary Session 1
Hepatitis C – Addressing the Challenge
16:00-17:30 Pipeline Showcase: New Drugs on the Horizon
17:30-18:00

Coffee Break and Poster Exhibition

18:00-19:15
SATELLITE SYMPOSIUM
JANSSEN PHARMECUTICALS
DAAs: Raising standards in patient care
19:15-20:30
Welcome Reception - Sponsored by Abbott

 
Friday, October 19, 2012
Hall A
Hall B
09:00-11:00
Plenary Session 2
HCV Direct Acting Antivirals: How have the treatment paradigms changed
11:00-11:30
Coffee Break
11:30-12:15
Session 3
Do we need to know genetic factors such as IL28B for treatment decision making?
Session 4
HCV therapy is for specialists only?
12:15-13:00
Lunch Break
13:00-14:15
SATELLITE SYMPOSIUM
MERCK SHARP & DOHME
Successful HCV Treatment in the Real World: Lessons From Clinical Practice
14:15-15:45
Plenary Session 5
Hepatitis: State of the Art Clinical Care
15:45-16:15
Coffee Break and Poster Prize Ceremony
16:15-17:00
Session 6
Should patients wait for DAA combination therapy?
Session 7
Resistance to HCV Protease Inhibitors: Game over?
17:00-17:30
Session 8
Interactive Case Session: How to treat HCV relapse after Liver Transplant?
Session 9
Interactive Case Session: How to treat HCV in HIV coinfection
Supported by an unrestricted grant from Boehringer Ingelheim

 
Saturday, October 20, 2012
Hall A
08:30-10:30
Plenary Session 10
HBV therapy in 2012
10:30-11:00

Coffee Break

11:00-11:45
Plenary Session 11
Interactive Case Session and Discussion: The challenging hepatitis B Case
Supported by an unrestricted grant from Gilead Sciences Europe Ltd
11:45-12:45
Plenary Session 12 
HCV – Looking to the Future
12:45-13:00

Farewell Toast


Home    Contact Us   
 
Copyright © 2007 comtecmed.com. All rights reserved.   The website was last updated on 04/02/2014 Created by     WebStudio.co.il